Taken together, via gene editing, we generated three RCC cell lines with the same genetic background, endogenously expressing either the G0, G1, or G2 APOL1 variants, thus enabling comparative analysis of the effects of each variant in RCC cells. This evidence concerns the gene APOL1 and renal cell adenocarcinoma.